Keyphrases
COVID-19
100%
Chronic Kidney Disease
82%
Acute Kidney Injury
71%
Meta-analysis
58%
Kidney Disease
56%
Confidence Interval
55%
Genome-wide Association Study
51%
Electronic Health Records
48%
Large Language Models
44%
Health Systems
43%
Apolipoprotein L1 (APOL1)
38%
Artificial Intelligence
38%
Whole Genome Sequencing
38%
Estimated Glomerular Filtration Rate
35%
Type 2 Diabetes Mellitus (T2DM)
34%
Kidney
34%
Mount Sinai
34%
Hospitalization
32%
African Ancestry
30%
Machine Learning
30%
United States
29%
Kidney Function
28%
Critically Ill Patients
28%
Deep Learning
28%
Diabetic Kidney Disease
26%
Adjusted Odds Ratio
26%
Hospitalized Patients
26%
Patients with COVID-19
26%
European Ancestry
25%
Hypertension
25%
Biobank
25%
Area under the Receiver Operating Characteristic Curve
24%
Precision Medicine
24%
New York City
23%
Natural Language Processing
22%
SARS-CoV-2 Infection
22%
GPT-4
22%
High Risk
21%
Machine Learning Models
21%
Rare Variants
21%
Genetic Architecture
20%
Electronic Health Record Data
20%
In-hospital Mortality
20%
Dialysis
19%
Odds Ratio
19%
National Trends
18%
End-stage Renal Disease
18%
Heart Failure
18%
Gain-of-function mutation
18%
Intensive Care Unit
18%
Medicine and Dentistry
COVID-19
79%
Chronic Kidney Disease
68%
Acute Kidney Injury
55%
Meta-Analysis
41%
Nephropathy
38%
Systematic Review
37%
Odds Ratio
34%
Biological Marker
33%
Kidney Function
32%
Electronic Health Record
29%
Medicine
28%
Cardiovascular System
28%
Health System
28%
Creatinine
27%
Glomerular Filtration Rate
25%
End Stage Renal Disease
25%
Infection
25%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Electrocardiogram
23%
Disease
23%
Human Immunodeficiency Virus
22%
Congestive Heart Failure
22%
Renal Failure
21%
Language Processing
19%
Diabetic Nephropathy
19%
Cohort Analysis
17%
Alanine Aminotransferase
17%
Cardiovascular Disease
17%
Diseases
17%
Hemodialysis
17%
Genetic Risk
16%
Coronary Artery Disease
16%
Clinician
16%
Nephrology
15%
Apolipoprotein L1
15%
Disease Exacerbation
14%
Acute Renal Failure
13%
Diagnosis
13%
Hospital Mortality
13%
Retrospective Cohort Study
13%
Personalized Medicine
13%
Albuminuria
13%
Hazard Ratio
13%
Echocardiography
12%
Cardiovascular Risk
12%
Maturity Onset Diabetes of the Young
11%
Comorbidity
11%
Clinical Trial
11%
Observational Study
11%
Sequela
11%